↓ Skip to main content

Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients

Overview of attention for article published in European Journal of Medical Research, August 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients
Published in
European Journal of Medical Research, August 2012
DOI 10.1186/2047-783x-17-25
Pubmed ID
Authors

Yang Wang, Li Pan, Xiaofang Sheng, Yin Mao, Yu Yao, Enmin Wang, Nan Zhang, Jiazhong Dai

Abstract

Bevacizumab has been suggested as a new treatment modality for cerebral radiation necrosis due to its ability to block the effects of vascular endothelial growth factor (VEGF) in leakage-prone capillaries, though its use still remains controversial in clinical practice.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 2%
Unknown 65 98%

Demographic breakdown

Readers by professional status Count As %
Other 11 17%
Researcher 11 17%
Student > Ph. D. Student 6 9%
Student > Master 6 9%
Student > Doctoral Student 5 8%
Other 13 20%
Unknown 14 21%
Readers by discipline Count As %
Medicine and Dentistry 31 47%
Biochemistry, Genetics and Molecular Biology 5 8%
Neuroscience 4 6%
Agricultural and Biological Sciences 3 5%
Nursing and Health Professions 3 5%
Other 6 9%
Unknown 14 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2012.
All research outputs
#22,758,309
of 25,373,627 outputs
Outputs from European Journal of Medical Research
#728
of 923 outputs
Outputs of similar age
#168,511
of 186,640 outputs
Outputs of similar age from European Journal of Medical Research
#2
of 2 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 923 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,640 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.